Related Experiment Videos
Predictive risk factors for early mortality in operative treatment for chronic ischemic mitral insufficiency
Oktay Burma1, Hasim Ustunsoy, M Adnan Celkan
1Department of Cardiovascular Surgery, School of Medicine, Gaziantep University, Gaziantep, Turkey. oburma@hotmail.com <oburma@hotmail.com>
Insights
This study identified key factors influencing early death in patients undergoing combined coronary artery bypass grafting and mitral valve surgery for ischemic mitral insufficiency. Advanced age and specific cardiac conditions significantly increase mortality risk.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Ischemic Mitral Insufficiency
Background:
- Combined coronary artery bypass grafting (CABG) and mitral valve surgery carry high risks.
- Ischemic mitral insufficiency often necessitates complex surgical intervention.
Purpose of the Study:
- To analyze factors affecting early mortality in patients undergoing CABG + mitral valve surgery.
- To identify demographic, preoperative, and perioperative risk factors for in-hospital mortality.
Main Methods:
- Retrospective analysis of 68 patients undergoing combined CABG and mitral valve surgery.
- Evaluation of demographic and clinical data to determine mortality predictors.
Main Results:
- The early mortality rate was 13.2% (9/68).
- Significant risk factors for mortality included: NYHA class > or =3, elevated left ventricle end-systolic volume/diameter, longer cardiopulmonary perfusion time, unstable angina, intra-aortic balloon use, and age >65.
Conclusions:
- Despite high risks, surgery can improve quality of life and prolong survival for patients with ischemic mitral insufficiency.
- Identifying and managing identified risk factors is crucial for improving surgical outcomes.
Background:
The combination of coronary artery bypass grafting and mitral valve surgeries is closely associated with high in-hospital mortality and morbidity. In this study, we sought to analyze the factors that influence early mortality in 68 patients undergoing coronary artery bypass grafting + mitral valve surgery due to ischemic mitral insufficiency.
Methods:
Of 1183 patients undergoing coronary bypass surgery between April 2002 and June 2006, 68 patients (42 male and 26 female) 42 to 78 years of age (mean +/- SD, 59.3 +/- 9.1) underwent mitral valve surgery accompanying coronary bypass surgery (survival, n = 59; mortality, n = 9). The cases were analyzed regarding the demographic, preoperative, and perioperative risk factors that influence mortality.
Results:
The early mortality rate was found to be 13.2% (9/68) in patients with ischemic mitral regurgitation undergoing simultaneous coronary bypass and mitral valve surgeries. New York Heart Association class > or =3, left ventricle end-systolic volume, left ventricle end-systolic diameter, cardiopulmonary perfusion time, preoperative unstable angina pectoris, intra-aortic balloon application, and age >65 years were determined to be statistically significant risk factors that influence early in-hospital mortality.Conclusion. Surgery, despite having a high mortality risk in patients with ischemic mitral insufficiency, is considered to be a treatment measure that generally improves the quality of life and prolongs life.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management